Catalyst Pharmaceuticals Inc (CPRX) Return on Investment ROI from the first quarter of 2026 to first quarter of 2025 and for the year 2026, average high and low, overall ranking from Mar 31 2026 to Mar 31 2025 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Catalyst Pharmaceuticals Inc   (NASDAQ: CPRX)


Catalyst Pharmaceuticals Inc's ROI from its first quarter of 2026 to the first quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Catalyst Pharmaceuticals Inc's ROI in the first quarter of 2026?
Catalyst Pharmaceuticals Inc achieved a return on average invested assets (ROI) of 23.58 % in its first quarter of 2026, this is above CPRX's average return on investment of -9.43%.
Catalyst Pharmaceuticals Inc invested over the 12 months ending in its first quarter of 2026 $938 million

ROI fell compared to the fourth quarter of 2025, despite the net income growth of 20.94% from the fourth quarter of 2025.

Within the Healthcare sector 48 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Mar 31 2026 quarter, so far to 242, from total ROI ranking in the fourth quarter of 2025 at 270.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter
Y / Y Investment Change TTM 33.65 % 37.13 % 47.64 % 58.16 % 64.44 %
Y / Y Net Income Change TTM 12.15 % 30.78 % 101.54 % 225.69 % 747.91 %
Investment (TTM) in Millions 1,015 957 923 859 797
Return On Investment (TTM) 23.58 % 24.25 % 26.29 % 27.33 % 28.11 %
CPRX's Overall Ranking # 242 # 270 # 215 # 201 # 195
Seq. Investment Change TTM 6.17 % 6.83 % 8.39 % 8.72 % 8.92 %
Seq. Net Income Change TTM 3.26 % -1.49 % 4.26 % 5.73 % 20.42 %
Net Income (TTM) in Millions 221 214 218 209 197

CPRX Company Profile >> Back to CPRX Roi Comparisons >> See Annual CPRX Return On Investment



Return On Investment CPRX's Ranking
Within: No.
Industry # 25
Sector # 49
Overall # 242

Return On Investment Statistics
High Average Low
62.65 %
-9.43 %
-95.13 %
(Sep 30 2020)   (Jun 30 2012)







Financial Statements
Catalyst Pharmaceuticals Inc's I. Quarter Investments $ 1,015 Millions CPRX's Balance sheet
Catalyst Pharmaceuticals Inc's I. Quarter Income $ 64 Millions Quarterly CPRX's Income Statement
CPRX's Income by Division See CPRX's Income by Division


CPRX Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 957 731 394 318 211
Y / Y Investment Growth 30.94 % 85.44 % 23.9 % 50.93 % 24.25 %
Net Income in Millions 214 164 71 83 39
Y / Y Net Income Growth 30.78 % 129.5 % -14.05 % 110.42 % -47.35 %
Annual Return On Investment 22.4 % 22.43 % 18.12 % 26.12 % 18.74 %


Annual Roi Comment
In the fiscal year 2025 ROI deteriorated to 22.4 %, despite net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
CPRX's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for CPRX's Competitors
Subscribers only: Roi for Catalyst Pharmaceuticals Inc's Suppliers
Subscribers only: Return On Investment for CPRX's Customers

Other Ratios
CPRX's Roa CPRX's Inventory Turnover Ratio CPRX's Growth Rates CPRX's Dividend Statistics
CPRX's Profitability Ratios CPRX's Asset Turnover Ratio CPRX's Dividend Growth
CPRX's Roe CPRX's Valuation Ratios CPRX's Financial Strength Ratios CPRX's Dividend Payout Ratio



Companies with similar Return On Investment at Mar 31 2026, within Healthcare Sector ROI
Q32 Bio Inc   58.17 %
Oramed Pharmaceuticals Inc  54.33 %
Aurinia Pharmaceuticals Inc   54.02 %
Vaxart Inc   51.45 %
Escalon Medical Corp   51.07 %
Tg Therapeutics Inc   50.62 %
Zevra Therapeutics Inc   50.45 %
Idexx Laboratories Inc  50.05 %
Theravance Biopharma inc   43.85 %
Elite Pharmaceuticals Inc   43.22 %
Dariohealth Corp   40.59 %
Innoviva Inc   36.71 %
Indivior Pharmaceuticals Inc   36.55 %
Eli Lilly And Company  36.13 %
Abeona Therapeutics Inc   35.03 %
Lifemd Inc   34.80 %
Acadia Pharmaceuticals Inc   34.03 %
Mettler toledo International Inc   33.62 %
Adma Biologics Inc   30.38 %
Medpace Holdings Inc   30.34 %
Spero Therapeutics Inc   29.59 %
Rafael Holdings Inc  28.08 %
Incyte Corporation  27.50 %
Carlisle Companies Incorporated  24.39 %
Iradimed Corporation  23.59 %
Catalyst Pharmaceuticals Inc   23.58 %
Engene Therapeutics Inc   22.76 %
Protalix Biotherapeutics inc   22.70 %
Electromed Inc   22.36 %
Dexcom Inc   22.17 %

Date modified: 2026-06-22T14:32:46+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.